Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-12
2008-10-21
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07439227
ABSTRACT:
This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.
REFERENCES:
patent: 6927208 (2005-08-01), Wenger et al.
patent: WO 98/28328 (1998-07-01), None
patent: WO 98/28329 (1998-07-01), None
patent: WO 00/01715 (2000-01-01), None
patent: WO 2005/021028 (2005-03-01), None
Watashi et al., Hepatology, 2003, vol. 38, pp. 1282-1288.
Nakagawa et al., Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem. Biophys. Res. Commun. 313: 42-7 (2004).
Watashi, K. et al., Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 38: 1282-1288 (2003).
Inoue K. et al., Interferon combined with cyclosporine treatment as an effective countermeasure . . . Transplantation Proceedings, Orlando, FL, vol. 37, pp. 1233-1234, 2005.
Inoue K. et al., Combined interferon alpha2b and cyclosporin A . . . J. Gastroenterol. 38: 567-72 (2003).
Huebler F. et al., Synthetic routes to NEt-Xaa4-cyclosporin A derivatives as potential anti-HIV I drugs. Tetrahedron Lett. (Elsevier, Amsterdam) 41: 7193-6 (2000).
Xia Wei-Liang et al., Inhibitory effect of cyclosporine A on hepatitis B . . . Hepatobiliary & Pancreatic Diseases International 4: 18-22 (2005) (ISSN 1499-3872).
Hansson M. et al., The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 . . . J. Bioenergetics & Biomembranes (Plenum, N.Y.) 36: 407-13 (2004).
Dumont Jean-Maurice
Mauvernay Rolland-Yves
Scalfaro Pietro
Vuagniaux Gregoire
Tate Christopher R.
Teller Roy
Voellmy Richard
LandOfFree
Use of selected cyclosporins for the treatment of hepatitis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of selected cyclosporins for the treatment of hepatitis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selected cyclosporins for the treatment of hepatitis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3991507